Salubris Pharmaceuticals
   HOME
*





Salubris Pharmaceuticals
Shenzhen Salubris Pharmaceuticals (; ) is a Chinese pharmaceutical company. Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019. Shenzhen Salubris is headed by the billionaire Ye Chenghai Ye Chenghai (; born 15 August 1943) is a Chinese billionaire businessman and former politician, the head of Shenzhen Salubris Pharmaceuticals. He is a Hakka people, Hakka born in Meizhou, Guangdong. He served as Vice Mayor of Shenzhen before quitti .... References {{Pharmaceutical companies of China Companies based in Shenzhen Companies listed on the Shenzhen Stock Exchange Pharmaceutical companies of China Chinese companies established in 1998 ...
[...More Info...]      
[...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]  


picture info

Shenzhen
Shenzhen (; ; ; ), also historically known as Sham Chun, is a major sub-provincial city and one of the special economic zones of China. The city is located on the east bank of the Pearl River estuary on the central coast of southern province of Guangdong, bordering Hong Kong to the south, Dongguan to the north, and Huizhou to the northeast. With a population of 17.56 million as of 2020, Shenzhen is the third most populous city by urban population in China after Shanghai and Beijing. Shenzhen is a global center in technology, research, manufacturing, business and economics, finance, tourism and transportation, and the Port of Shenzhen is the world's fourth busiest container port. Shenzhen is classified as a Large-Port Megacity, the largest type of port-city in the world. Shenzhen roughly follows the administrative boundaries of Bao'an County, which was established since imperial times. The southern portion of Bao'an County was seized by the British after the Opium Wars an ...
[...More Info...]      
[...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]  


Ye Chenghai
Ye Chenghai (; born 15 August 1943) is a Chinese billionaire businessman and former politician, the head of Shenzhen Salubris Pharmaceuticals. He is a Hakka people, Hakka born in Meizhou, Guangdong. He served as Vice Mayor of Shenzhen before quitting politics and entering business. As of May 2015, his net worth is estimated at US$4.2 billion. References

1943 births Billionaires from Guangdong Living people Place of birth missing (living people) Chinese company founders Pharmaceutical company founders Businesspeople from Meizhou Politicians from Meizhou Political office-holders in Guangdong Hakka politicians {{Business-bio-stub ...
[...More Info...]      
[...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]  


picture info

Companies Based In Shenzhen
A company, abbreviated as co., is a legal entity representing an association of people, whether natural, legal or a mixture of both, with a specific objective. Company members share a common purpose and unite to achieve specific, declared goals. Companies take various forms, such as: * voluntary associations, which may include nonprofit organizations * business entities, whose aim is generating profit * financial entities and banks * programs or educational institutions A company can be created as a legal person so that the company itself has limited liability as members perform or fail to discharge their duty according to the publicly declared incorporation, or published policy. When a company closes, it may need to be liquidated to avoid further legal obligations. Companies may associate and collectively register themselves as new companies; the resulting entities are often known as corporate groups. Meanings and definitions A company can be defined as an "artificial per ...
[...More Info...]      
[...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]  


Companies Listed On The Shenzhen Stock Exchange
This is a list of companies on the Shenzhen Stock Exchange up to 2011, along with their capital, industry, and listing date. Many of these are subsidiaries of state-owned enterprises. 000001-000099 000100-000499 000500-000599 000600-000699 000700-000799 000800-000899 000900-001999 2001-2100 {, , - , colspan=7, , - , - , align="center" style="background:#f0f0f0;", Code , align="center" style="background:#f0f0f0;", Short-name , align="center" style="background:#f0f0f0;", Listing date , align="center" style="background:#f0f0f0;", Issued capital , align="center" style="background:#f0f0f0;", Negotiable capital , align="center" style="background:#f0f0f0;", Industry , align="center" style="background:#f0f0f0;", Http , - , 002001, , NHU, , 25.06.2004, , 483,964,000, , 440,019,780, , Petrochemicals, , http://www.cnhu.com , - , 002002, , JSQH, , 25.06.2004, , 166,894,000, , 122,907,578, , Petrochemicals, , http://www.chinaqionghua.com ...
[...More Info...]      
[...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]  


picture info

Pharmaceutical Companies Of China
A medication (also called medicament, medicine, pharmaceutical drug, medicinal drug or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management. Drugs are classified in multiple ways. One of the key divisions is by level of control, which distinguishes prescription drugs (those that a pharmacist dispenses only on the order of a physician, physician assistant, or qualified nurse) from over-the-counter drugs (those that consumers can order for themselves). Another key distinction is between traditional small molecule drugs, usually derived from chemical synthesis, and biopharmaceuticals, which include recombinant proteins, vaccines, blood products used therapeutically (such as IVIG), gene therapy, monoclonal antibodies and cell therapy (for instance, stem cell therapies). Other ...
[...More Info...]      
[...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]